← Leaderboards
Michael Simons
Yale University
$49,269,368
Attributed
$57,626,051
Total exposure
27
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$78,195,414 · 29
By mechanism
R01$43,539,999 · 10
P01$30,065,687 · 10
P50$3,018,870 · 3
P30$1,153,026 · 1
M01$387,832 · 3
R13$30,000 · 2
Top collaborators
- Martin A. Schwartz10 shared
- Anne Christine Eichmann4 shared
- George Tellides4 shared
- Zoltan P Arany3 shared
- Timothy Tun Hla1 shared
Most similar at Yale University
Same institution · by research overlap
- Martin A. Schwartz$34,384,106
- Chenxiang Lin$8,574,232
- Anne Christine Eichmann$13,173,934
- William C. Sessa$34,897,684
- Themis R Kyriakides$9,871,661
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMolecularBlood VesselsEndothelial CellsVascular Endothelial Growth FactorsRegulationAngiogenesisEventResponseNovel TherapeuticsSignal PathwayGrowthPlayAdultTissuesBiologicalProgramsFibroblast Growth FactorIn VivoPathway InteractionsEndotheliumShear StressReceptorPhenotype
Grant awards (150)
Acetate and Endothelial Pathobiology$708,532
R01 · FY2025 · HL
A QUANTITATIVE, PREDICTIVE MODEL OF VASCULAR REMODELING IN HEALTH AND DISEASE$669,583
R01 · FY2025 · HL
Ischemia/Reperfusion injury and Myocardial edema$659,514
R01 · FY2025 · HL · contact PI
Endothelial-to-mesenchymal transition and atherosclerosis$818,888
R01 · FY2024 · HL
Vascular smooth muscle cell heterogeneity and disease$817,799
R01 · FY2024 · HL · contact PI
Acetate and Endothelial Pathobiology$705,110
R01 · FY2024 · HL
A QUANTITATIVE, PREDICTIVE MODEL OF VASCULAR REMODELING IN HEALTH AND DISEASE$686,458
R01 · FY2024 · HL
Ischemia/Reperfusion injury and Myocardial edema$645,489
R01 · FY2024 · HL · contact PI
Endothelial-to-mesenchymal transition and atherosclerosis$835,600
R01 · FY2023 · HL
Vascular smooth muscle cell heterogeneity and disease$831,140
R01 · FY2023 · HL · contact PI
Acetate and Endothelial Pathobiology$742,438
R01 · FY2023 · HL
Ischemia/Reperfusion injury and Myocardial edema$610,264
R01 · FY2023 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,912,161
P01 · FY2022 · HL · contact PI
Endothelial-to-mesenchymal transition and atherosclerosis$835,600
R01 · FY2022 · HL
Vascular smooth muscle cell heterogeneity and disease$830,638
R01 · FY2022 · HL · contact PI
Dynamic control of vascular permeability in development and disease$813,824
R01 · FY2022 · HL
ERK signaling in arteriogenesis$562,519
P01 · FY2022 · HL · contact PI
Administrative Core$93,460
P01 · FY2022 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,917,856
P01 · FY2021 · HL · contact PI
Endothelial-to-mesenchymal transition and atherosclerosis$835,601
R01 · FY2021 · HL
Vascular smooth muscle cell heterogeneity and disease$826,040
R01 · FY2021 · HL · contact PI
Dynamic control of vascular permeability in development and disease$821,781
R01 · FY2021 · HL
ERK signaling in arteriogenesis$566,497
P01 · FY2021 · HL · contact PI
Syndecan function in endothelial cells$563,755
R01 · FY2021 · HL · contact PI
Administrative Core$98,485
P01 · FY2021 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,911,829
P01 · FY2020 · HL · contact PI
Dynamic control of vascular permeability in development and disease$829,318
R01 · FY2020 · HL
Endothelial-to-mesenchyma transition and atherosclerosis$800,131
R01 · FY2020 · HL
Syndecan function in endothelial cells$557,755
R01 · FY2020 · HL · contact PI
ERK signaling in arteriogenesis$539,385
P01 · FY2020 · HL · contact PI
Administrative Core$93,661
P01 · FY2020 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,913,890
P01 · FY2019 · HL · contact PI
Dynamic control of vascular permeability in development and disease$836,855
R01 · FY2019 · HL
Endothelial-to-mesenchyma transition and atherosclerosis$808,131
R01 · FY2019 · HL
ERK signaling in arteriogenesis$569,063
P01 · FY2019 · HL · contact PI
Syndecan function in endothelial cells$568,080
R01 · FY2019 · HL · contact PI
Administrative Core$98,485
P01 · FY2019 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,890,562
P01 · FY2018 · HL · contact PI
Endothelial-to-mesenchyma transition and atherosclerosis$817,156
R01 · FY2018 · HL
Arteriogenesis and Branching$553,588
R01 · FY2018 · HL · contact PI
ERK signaling in arteriogenesis$553,583
P01 · FY2018 · HL · contact PI
Syndecan function in endothelial cells$541,600
R01 · FY2018 · HL · contact PI
Administrative Core$96,601
P01 · FY2018 · HL · contact PI
Endothelial-to-mesenchyma transition and atherosclerosis$827,743
R01 · FY2017 · HL
Angiogenesis and Ischemia$581,916
R01 · FY2017 · HL · contact PI
Arteriogenesis and Branching$551,876
R01 · FY2017 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,874,925
P01 · FY2016 · HL · contact PI
Raf 1-ERK cross-talk in Arteriogenesis$651,577
P01 · FY2016 · HL · contact PI
Angiogenesis and Ischemia$579,365
R01 · FY2016 · HL · contact PI
Arteriogenesis and Branching$547,048
R01 · FY2016 · HL · contact PI
Syndecan Function in Endothelial Cells$523,526
R01 · FY2016 · HL · contact PI
eN0S/TSP2$459,858
P01 · FY2016 · HL · contact PI
Shear Stress Activation of Arteriogenic Signaling$304,966
P01 · FY2016 · HL · contact PI
Imaging/Surgery$148,610
P01 · FY2016 · HL · contact PI
Cell Isolation and Mouse Genotyping$143,742
P01 · FY2016 · HL · contact PI
Bioreactor$88,847
P01 · FY2016 · HL · contact PI
Administrative Core$77,325
P01 · FY2016 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,868,235
P01 · FY2015 · HL · contact PI
Raf 1-ERK cross-talk in Arteriogenesis$595,775
P01 · FY2015 · HL · contact PI
Angiogenesis and Ischemia$564,682
R01 · FY2015 · HL · contact PI
Arteriogenesis and Branching$542,022
R01 · FY2015 · HL · contact PI
Syndecan Function in Endothelial Cells$501,009
R01 · FY2015 · HL · contact PI
eN0S/TSP2$448,125
P01 · FY2015 · HL · contact PI
Shear Stress Activation of Arteriogenic Signaling$375,762
P01 · FY2015 · HL · contact PI
Imaging/Surgery$146,539
P01 · FY2015 · HL · contact PI
Cell Isolation and Mouse Genotyping$142,746
P01 · FY2015 · HL · contact PI
Bioreactor$80,308
P01 · FY2015 · HL · contact PI
Administrative Core$78,980
P01 · FY2015 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,862,673
P01 · FY2014 · HL · contact PI
Arteriogenesis and Arterial Branching$599,327
R01 · FY2014 · HL · contact PI
Raf 1-ERK cross-talk in Arteriogenesis$576,598
P01 · FY2014 · HL · contact PI
Angiogenesis and Ischemia$540,016
R01 · FY2014 · HL · contact PI
Syndecan Function in Endothelial Cells$488,417
R01 · FY2014 · HL · contact PI
eN0S/TSP2$465,499
P01 · FY2014 · HL · contact PI
Shear Stress Activation of Arteriogenic Signaling$378,748
P01 · FY2014 · HL · contact PI
Imaging/Surgery$144,248
P01 · FY2014 · HL · contact PI
Cell Isolation and Mouse Genotyping$139,100
P01 · FY2014 · HL · contact PI
Bioreactor$79,900
P01 · FY2014 · HL · contact PI
Administrative Core$78,580
P01 · FY2014 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,805,417
P01 · FY2013 · HL · contact PI
Arteriogenesis and Arterial Branching$584,915
R01 · FY2013 · HL · contact PI
Raf 1-ERK cross-talk in Arteriogenesis$532,361
P01 · FY2013 · HL · contact PI
eN0S/TSP2$458,656
P01 · FY2013 · HL · contact PI
Syndecan Function in Endothelial Cells$452,881
R01 · FY2013 · HL · contact PI
Shear Stress Activation of Arteriogenic Signaling$367,510
P01 · FY2013 · HL · contact PI
Imaging/Surgery$139,949
P01 · FY2013 · HL · contact PI
Cell Isolation and Mouse Genotyping$133,334
P01 · FY2013 · HL · contact PI
Bioreactor$97,369
P01 · FY2013 · HL · contact PI
Administrative Core$76,238
P01 · FY2013 · HL · contact PI
Molecular Mechanisms of Arterigenesis$1,857,092
P01 · FY2012 · HL · contact PI
Arteriogenesis and Arterial Branching$609,585
R01 · FY2012 · HL · contact PI
Angiogensis and ischemia$525,342
R01 · FY2012 · HL · contact PI
Syndecan Function in Endothelial Cells$520,531
R01 · FY2012 · HL · contact PI
Raf 1-ERK cross-talk in Arteriogenesis$488,257
P01 · FY2012 · HL · contact PI
Administrative Core$79,801
P01 · FY2012 · HL · contact PI
Arteriogenesis and Arterial Branching$610,915
R01 · FY2011 · HL · contact PI
Syndecan Function in Endothelial Cells$530,943
R01 · FY2011 · HL · contact PI
Angiogensis and ischemia$528,256
R01 · FY2011 · HL · contact PI
Syndecan Function in Endothelial Cells$650,541
R01 · FY2010 · HL · contact PI
Yale Cardiovascular Center faculty recruitment$577,701
P30 · FY2010 · HL · contact PI
Angiogensis and ischemia$533,303
R01 · FY2010 · HL · contact PI
Arteriogenesis and arterial branching$509,279
R01 · FY2010 · HL · contact PI
Syndecan Function in Endothelial Cells$658,812
R01 · FY2009 · HL · contact PI
Yale Cardiovascular Center faculty recruitment$575,325
P30 · FY2009 · HL · contact PI
Angiogensis and ischemia$543,567
R01 · FY2009 · HL · contact PI
Arteriogenesis and arterial branching$527,192
R01 · FY2009 · HL · contact PI
2009 Vascular Biology Gordon Research Conference$15,000
R13 · FY2009 · HL · contact PI
Syndecan Function in Endothelial Cells$659,497
R01 · FY2008 · HL · contact PI
Angiogensis and ischemia$419,837
R01 · FY2008 · HL · contact PI
Arteriogenesis and arterial branching$340,576
R01 · FY2008 · HL · contact PI
Arteriogenesis and arterial branching$171,504
R01 · FY2008 · HL · contact PI
Angiogensis and ischemia$91,758
R01 · FY2008 · HL · contact PI
NAVBO Workshop: Biology of Signaling in the Cardiovascular System$15,000
R13 · FY2008 · HL
Arteriogenesis and arterial branching$506,683
R01 · FY2007 · HL · contact PI
Syndecan Function in Endothelial Cells$341,132
R01 · FY2007 · HL · contact PI
Angiogenesis in Myocardial Ischemia$341,132
R01 · FY2007 · HL · contact PI
Syndecan Function in Endothelial Cells$351,321
R01 · FY2006 · HL · contact PI
Angiogenesis in Myocardial Ischemia$351,321
R01 · FY2006 · HL · contact PI
Syndecan Function in Endothelial Cells$359,775
R01 · FY2005 · HL
Angiogenesis in Myocardial Ischemia$359,494
R01 · FY2005 · HL
Peptide Regulators of Angiogenesis$334,339
R01 · FY2005 · HL
Syndecan Function in Endothelial Cells$358,650
R01 · FY2004 · HL
Angiogenesis in Myocardial Ischemia$357,863
R01 · FY2004 · HL
Peptide Regulators of Angiogenesis$334,339
R01 · FY2004 · HL
Peptide Regulators of Angiogenesis$334,510
R01 · FY2003 · HL
Peptide Regulators of Angiogenesis$363,840
R01 · FY2002 · HL
SYNDECAN FUNCTION IN ENDOTHELIAL CELLS$317,696
R01 · FY2002 · HL
ANGIOGENESIS AND MYOCARDIAL ISCHEMIA$287,423
R01 · FY2002 · HL
Syndecan-4 signaling in angiogenesis$219,340
P50 · FY2002 · HL
ANGIOGENESIS AND MYOCARDIAL ISCHEMIA$340,501
R01 · FY2001 · HL
SYNDECAN FUNCTION IN ENDOTHELIAL CELLS$296,459
R01 · FY2001 · HL
STIMULATION OF HUMAN CORONARY ANGIOGENESIS WITH BASIC FGF$274,326
P50 · FY2001 · HL
Syndecan-4 signaling in angiogenesis$219,340
P50 · FY2001 · HL
Syndecan-4 signaling in angiogenesis$219,340
P50 · FY2001 · HL
SYNDECAN FUNCTION IN ENDOTHELIAL CELLS$43,971
R01 · FY2001 · HL
FIBROBLAST GROWTH FACTOR 2 IN CORONARY ARTERY DISEASE$0
M01 · FY2001 · RR
RFGF 2 IN SUBJECTS W/ ADVANCED CORONARY HEART DISEASE$0
M01 · FY2001 · RR
ENDOTHELIAL CELL SIGNALING AND CARDIAC ANGIOGENESIS$1,754,723
P50 · FY2000 · HL
ANGIOGENESIS AND MYOCARDIAL ISCHEMIA$341,691
R01 · FY2000 · HL
SYNDECAN FUNCTION IN ENDOTHELIAL CELLS$331,010
R01 · FY2000 · HL
Syndecan-4 signaling in angiogenesis$219,340
P50 · FY2000 · HL
BFGF ANGIOGENESIS STUDY$193,916
M01 · FY2000 · RR
BFGF ANGIOGENESIS STUDY$193,916
M01 · FY2000 · RR
STIMULATION OF HUMAN CORONARY ANGIOGENESIS WITH BASIC FGF$112,461
P50 · FY2000 · HL
FIBROBLAST GROWTH FACTOR 2 IN CORONARY ARTERY DISEASE$0
M01 · FY2000 · RR
FIBROBLAST GROWTH FACTOR 2 IN CORONARY ARTERY DISEASE$0
M01 · FY2000 · RR
FIBROBLAST GROWTH FACTOR 2 IN CORONARY ARTERY DISEASE$0
M01 · FY2000 · RR
RFGF 2 IN SUBJECTS W/ ADVANCED CORONARY HEART DISEASE$0
M01 · FY2000 · RR
RFGF 2 IN SUBJECTS W/ ADVANCED CORONARY HEART DISEASE$0
M01 · FY2000 · RR
RFGF 2 IN SUBJECTS W/ ADVANCED CORONARY HEART DISEASE$0
M01 · FY2000 · RR